Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Metabolism: Clinical and Experimental|February 13, 2007
Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemiaMirjam Langeveld, Saskia Scheij, Peter Dubbelhuis, et al.
Molecular Genetics and Metabolism|July 9, 2026
Toward standardized care: International expert survey on pregnancy management in long-chain fatty acid oxidation disorders and unmet needsKarina A Zeyer, Terry G J Derks, Mirjam Langeveld, et al.
JIMD Reports|August 9, 2019
The Mini Mental State Examination does not accurately screen for objective cognitive impairment in Fabry DiseaseSimon Körver, Sara A J van de Schraaf, Gert J Geurtsen, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 17, 2025
[Inherited metabolic disorders in adults:growing patient numbers, advanced diagnostic tools and new treatment modalities]Mirjam Langeveld, Martijn C G J Brouwers, Laura van Dussen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 1, 2008
Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher diseaseKaren Ghauharali-van der Vlugt, Mirjam Langeveld, Aldi Poppema, et al.
EMBO Molecular Medicine|September 22, 2025
Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived modelsAdriana S Passadouro, Berith M Balfoort, Mirjam Langeveld, et al.
Journal of Inherited Metabolic Disease|July 30, 2025
Myopathic Symptoms and Exercise Tolerance in Adolescent Patients With Long-Chain Fatty Acid Oxidation DisordersMarit Schwantje, Marco van Brussel, Tim Takken, et al.
Orphanet Journal of Rare Diseases|January 27, 2016
Position statement on the role of healthcare professionals, patient organizations and industry in European Reference NetworksCarla E M Hollak, Marieke Biegstraaten, Matthias R Baumgartner, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2011
Movement disorders in adult surviving patients with maple syrup urine diseaseMiryam Carecchio, Susanne A Schneider, Heidi Chan, et al.
Heart (British Cardiac Society)|April 30, 2024
Incidence and risk factors for development of left ventricular hypertrophy in Fabry diseaseEmanuele Monda, Athanasios Bakalakos, Robin Lachmann, et al.
Pageof 13